News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Silverman Joshua
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/03/2023 |
4
| Silverman Joshua (Director) has filed a Form 4 on AYRO, Inc.|
Txns:
| Sold 12,740 shares
@ $0.8152, valued at
$10.4k
|
|
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/09/2023 |
4
| Silverman Joshua (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 200,000 options to buy
@ $1.66, valued at
$332k
|
|
| 05/05/2023 |
4
| Silverman Joshua (Director) has filed a Form 4 on AYRO, Inc.|
Txns:
| Sold 11,927 shares
@ $0.4874, valued at
$5.8k
|
|
| 05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/28/2023 |
4
| Silverman Joshua (Director) has filed a Form 4 on Petros Pharmaceuticals, Inc.|
Txns:
| Exercised 6,722 restricted stock units
@ $0 |
|
| 03/31/2023 |
4
| Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.87, valued at
$17.4k
|
|
| 02/03/2023 |
4
| Silverman Joshua (Director) has filed a Form 4 on AYRO, Inc.|
Txns:
| Sold 7,171 shares
@ $0.7123, valued at
$5.1k
Granted 197,333 shares
@ $0 |
|
| 01/25/2023 |
4
| Silverman Joshua (Director) has filed a Form 4 on Petros Pharmaceuticals, Inc.|
Txns:
| Exercised 2,515 restricted stock units
@ $0 |
|
| 12/20/2022 |
4
| Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Sold 19,012 shares
@ $1.1719, valued at
$22.3k
|
|
| 12/01/2022 |
4/A
| Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 42,250 shares
@ $0 |
|
| 12/01/2022 |
4/A
| Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 75,000 options to buy
@ $6.07, valued at
$455.3k
|
|
| 11/17/2022 |
4
| Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 144,000 options to buy
@ $6.07, valued at
$874.1k
|
|
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/23/2022 |
4/A
| Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Acquired options to buy
@ $0 |
|
| 04/11/2022 |
4
| Silverman Joshua (Director) has filed a Form 4 on Petros Pharmaceuticals, Inc.|
Txns:
| Granted 67,227 restricted stock units
@ $0 |
|
| 04/06/2022 |
4
| Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 1,500 options to buy
@ $7.41, valued at
$11.1k
|
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2022 |
4
| Silverman Joshua (Director) has filed a Form 4 on Petros Pharmaceuticals, Inc.|
Txns:
| Granted 25,156 restricted stock units
@ $0 |
|
| 11/29/2021 |
4
| Silverman Joshua (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Bought 6,734 shares
@ $6.2991, valued at
$42.4k
Bought 3,266 shares
@ $7.0937, valued at
$23.2k
Bought 5,000 shares
@ $7.5543, valued at
$37.8k
|
|
| 10/15/2021 |
4
| Silverman Joshua (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 600,000 restricted stock units
@ $0 |
|
| 07/15/2021 |
4
| Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 90,000 shares
@ $0 |
|
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2021 |
4
| Silverman Joshua (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 38,325 shares
@ $4.94, valued at
$189.3k
Exercised 109,500 restricted stock units
@ $0 |
|
| 04/09/2021 |
4
| Silverman Joshua (Director) has filed a Form 4 on Petros Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $3.18, valued at
$159k
|
|
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2020 |
4/A
| Silverman Joshua (Director) has filed a Form 4 on AYRO, Inc.|
Txns:
| Granted 122,547 shares
@ $0 |
|
| 12/03/2020 |
4
| Silverman Joshua (Director) has filed a Form 4 on Neurotrope, Inc.|
Txns:
| Disposed/sold 100,000 shares
@ $0
Disposed/sold 9,375 options to buy
@ $19.2, valued at
$180k
Disposed/sold 124,275 options to buy
@ $10.56, valued at
$1.3M
Disposed/sold 10,000 options to buy
@ $19.1, valued at
$191k
Disposed/sold 167,000 options to buy
@ $19.62, valued at
$3.3M
Disposed/sold 10,000 options to buy
@ $8.912, valued at
$89.1k
Disposed/sold 150,000 options to buy
@ $3.93, valued at
$589.5k
Disposed/sold 10,000 options to buy
@ $4.06, valued at
$40.6k
Disposed/sold 10,000 options to buy
@ $0.8203, valued at
$8.2k
Disposed/sold 100,000 options to buy
@ $0.972, valued at
$97.2k
|
|
| 12/02/2020 |
4
| Silverman Joshua (Director) has filed a Form 4 on Petros Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 1,875 options to buy
@ $96, valued at
$180k
Granted 24,855 options to buy
@ $52.8, valued at
$1.3M
Granted 2,000 options to buy
@ $95.5, valued at
$191k
Granted 33,400 options to buy
@ $98.1, valued at
$3.3M
Granted 2,000 options to buy
@ $44.56, valued at
$89.1k
Granted 30,000 options to buy
@ $19.65, valued at
$589.5k
Granted 2,000 options to buy
@ $20.3, valued at
$40.6k
Granted 2,000 options to buy
@ $4.1, valued at
$8.2k
Granted 20,000 options to buy
@ $4.86, valued at
$97.2k
|
|
| 12/01/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|